Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management
Abstract There is paucity of data regarding the diagnostic yield and safety of skin biopsies in patients with acute myeloid leukemia (AML), though skin eruptions are common in these patients. We evaluated 216 patients treated in our hemato-oncology unit at a tertiary medical center between 2007 and...
Guardado en:
Autores principales: | Tamar Berger, Shany Sherman, Lucille Hayman, Ofir Wolach, Adi Shacham-Abulafia, Pia Raanani, Oren Pasvolsky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f52b36024e84838be76d296b1edf098 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe?
por: Mario Faenza, et al.
Publicado: (2021) -
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
por: Michael B. Atkins, et al.
Publicado: (2021) -
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
por: Pawel Rajwa, et al.
Publicado: (2021) -
Prognostic impact of pre-transplant chromosomal aberrations in peripheral blood of patients undergoing unrelated donor hematopoietic cell transplant for acute myeloid leukemia
por: Youjin Wang, et al.
Publicado: (2021) -
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
por: Siang-Boon Koh, et al.
Publicado: (2021)